Subscribe To
Cassava sciences stock undervalued with its $124 price target?
Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a...
January 31, 2023, 2:01 am
Royalty pharma: uncorrelated yield from pharmaceutical product in uncertain times
Royalty Pharma plc is an interesting investment fund that buys pharmaceutical royalties and generates a non-correlated yield. With the depressed ...
January 30, 2023, 3:19 pm
Final trades: stryker, davita, biotech and more
The "Halftime Report" traders give their top picks to watch for the second half....
January 30, 2023, 2:27 pm
Beyond cancer® appoints gavin choy, pharmd as chief operating officer
Dr. Choy brings more than 20+ years of pharmaceutical and biotechnology operating experience to Beyond Cancer GARDEN CITY, N.Y. and HAMILTON, Bermuda,...
January 30, 2023, 12:00 pm
Opthea to present at sequire biotechnology conference
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing no...
January 30, 2023, 6:00 am
Cidara therapeutics: fda approval dead ahead
Today, we are putting the spotlight on small biotech concern Cidara Therapeutics for the first time in ...
January 30, 2023, 5:23 am
What will 2023 bring for alexandria real estate equities?
Alexandria Real Estate Equities is the leading provider of high-demand biotech, agrifood, and life sciences office space. The company saw record leasi...
January 29, 2023, 12:44 pm
What will 2023 bring for alexandria real estate equities?
A slowdown in the biotech and life sciences industry isn't going to stop this top-tier stock from growi...
January 29, 2023, 7:15 am
Aerovate: developing an exciting pah drug, initiating with a buy
Aerovate is a SMID-cap biotech developing an inhaled imatinib for pulmonary arterial hypertension. AV-1...
January 29, 2023, 7:12 am
Jasper therapeutics announces closing of public offering of common stock and full exercise of underwriters’ option to purchase additional shares
REDWOOD CITY, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
January 27, 2023, 6:10 pm
Anebulo: interesting drug for cannabis intoxication, but the market potential remains unclear
Anebulo pharmaceutical is a US small-cap ($80M market cap) biotech company that is developing a phase 2...
January 27, 2023, 3:49 pm
biotech stocks reward shareholders who handle the bumpy ride
biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulte...
January 27, 2023, 2:56 pm
Biocorrx to present at sequire biotechnology conference on february 2nd
Presentation on Thursday, February 2, 2023 at 2:00 PM ET...
January 27, 2023, 8:30 am
The 3 best biotech stocks under $1 to buy for january
While biotech may be the next big thing, making money through it isn't easy. Indeed, investing in ...
January 26, 2023, 6:06 pm
Why shares of editas medicine jumped this week
It's been a seesaw month for the clinical-stage gene-editing biotech....
January 26, 2023, 6:04 pm
Sartorius stedim biotech s.a. (sdmhf) q4 2022 earnings call transcript
Sartorius Stedim biotech S.A. (OTCPK:SDMHF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM E...
January 26, 2023, 5:38 pm
Akoya bioscience: something special for investing in a spatial bioscience company
I will provide readers the basics of what a spatial biotech offers. A key catalyst should drive the fut...
January 26, 2023, 3:13 pm
Why shares of zencor rose this week
The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago....
January 26, 2023, 2:33 pm
: genelux ipo prices at bottom of range
Genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share range, for its stock market debut Thursday on the ...
January 26, 2023, 11:40 am
How will early 2023 layoffs affect these 5 biotech stocks?
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new...
January 26, 2023, 4:03 am